Emotional Dysfunction Clinical Trials
2 recruiting trials for Emotional Dysfunction. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Emotional Dysfunction clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Duke University (1), Oregon Health and Science University (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Repetitive Transcranial Magnetic Stimulation (rTMS) (device, 1 trial), followed by electrical scalp stimulation, Cognitive Restructuring.
Track Emotional Dysfunction trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Neurostimulation Versus Therapy for Problems With Emotions
The primary goal of this clinical trial is to evaluate the unique neural and behavioral effects of a one-session training combining emotion regulation skills training, with...
Optimizing Research With Diverse Families - Feasibility and Acceptability Study (FAST)
Evaluate feasibility and acceptability of recruiting Black and Hispanic families for an open label clinical trial of multinutrients while collecting real-time parent-reported...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Emotional Dysfunction, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Emotional Dysfunction, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Emotional Dysfunction, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.